Olivier Adotévi

19PUBLICATIONS
146CO-AUTHORS
Predictive and prognostic markersInnate immunityMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jan 13, 2026
Circulating Transcriptome Analysis Finds Gene Signatures and Immune Cell Activation and Abundance Predict Response to Immunotherapy in Bladder Cancer.

Sandy Chevrier, Corentin Richard, Olivier Adotévi

|Nov 24, 2025
Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines.

Agathe Carrier, Paolo Manghi, Carolina Alves Costa Silva

|Oct 20, 2025
Targeting SALL4 with an HLA Class I-Restricted TCR for Cancer Immunotherapy.

Myriam Ben Khelil, Maxime Fredon, Nawfel Adib

|Feb 20, 2025
Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer.

Alice Talpin, Ana Maia, Jean-Marie Carpier

|Jan 31, 2025
Predictive biomarkers and specific immune responses of COVID-19 mRNA vaccine in patients with cancer: prospective results from the CACOV-VAC trial.

Laurie Spehner, Emeline Orillard, Antoine Falcoz

|May 31, 2024
Impact of scFv on Functionality and Safety of Third-Generation CD123 CAR T Cells.

Maxime Fredon, Margaux Poussard, Sabeha Biichlé

Pageof 4

Frequent Collaborators

4 joint publications

Marie Kroemer

3 joint publications

Jeanne Galaine

3 joint publications

Romain Loyon

2 joint publications

Laura Boullerot